Research

The Research Center has over 30 years of clinical research experience and has administered over 300 research studies in a variety of neurological disorders.

Current Studies

Click on a study for more information
Alzheimer's Disease (click here)

We are currently enrolling in studies for Alzheimer’s Disease.

Please contact Estela at 619-432-0867.

Simufilam 50 mg Or 100 mg For Mild-To-Modeate Alzheimer’s Disease (REFOCUS_ALZ).https://clinicaltrials.gov/ct2/show/NCT05026177

A study of LY3372689 To Assess The Safety, Tolerability, And Efficacy In Participants With Alzheimer’s Disease.https://clinicaltrials.gov/ct2/show/NCT05063539

For more information, you can visit the patient website by clicking here

Myasthenia Gravis (click here)

We are currently enrolling in studies for Myasthenia Gravis.

Please contact Lupe at 619-432-0954.

Descartes-08 CAR-T Cells In Generalized Myasthenia Gravis (MG).https://clinicaltrials.gov/ct2/show/NCT04146051

Evaluating The Long Term Safety And Tolerability Of Efgartigimond PH20 SC Administered Subcutaneously In Patients With Generalized Myasthenia Gravis (ADAPTSC+).https://clinicaltrials.gov/ct2/show/NCT04818671

Multiple Sclerosis (click here)

We are currently enrolling in studies for Multiple Sclerosis.

Please contact Lupe at 619-432-0954.

A Study To Evaluate The Efficacy And Safety of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS) (Fenhance) .https://clinicaltrials.gov/ct2/show/NCT04586010

For more information, you can visit the patient website by clicking here.

Migraine (click here)

We are currently enrolling in studies for Migraine.

Please contact April at 619-432-0859.

Assessment of Safety of Nerivio for the Migraine Prevention .https://clinicaltrials.gov/ct2/show/NCT04828707

Multiple System Atrophy (MSA), Pure Autonomic Failure (PAF), Lewy Body Dementia (LBD) (click here)

We are currently enrolling in studies for Multiple System Atrophy, Pure Autonomic Failure, and Lewy Body Dementia.

Please contact April at 619-432-0859

Synuclein-One Study .https://clinicaltrials.gov/ct2/show/NCT04700722

Current Areas of Research

Alzheimer's Disease/Dementia
Headache/Migraine
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)

Menu


COVID-19 Update

While the state lifted it’s mask requirement, this does not include healthcare facilities. TNC will continue to require all patients to wear masks while in our offices regardless of vaccination status. We thank you for your assistance in helping protect the vulnerable among us.

Furthermore, in order to maintain your safety, we have continued the following practice policies:

  • Tele-visits (video visit) appointments are available to you.

  • Patients are required to wear a mask during their visit. Our staff and providers wear masks at all times.

  • Cleaning and sanitation protocols for all patient contact areas have been put in place to reduce the risk of transmission.

  • Pre-screening questions for COVID and symptoms we feel may be relevant will be discussed by telephone prior to appointment.

  • We will attempt to limit your time in the office for your safety and the safety of our staff.

  • Please do not bring a family member or friend into the office at your next appointment unless you are a minor or require a caregiver or translator – or if there is a medical necessity to have an accompanying person in the office with patient.